Procalcitonin Antibody Market Future Demand, Market Analysis & Outlook Report (2019-2026)
Procalcitonin (PCT) is a peptide precursor of the calcitonin hormone. Procalcitonin is a peptide that contains 116 amino acids and has an estimated molecular weight of 14.5 kDa. It can be separated into three parts: immature calcitonin, amino terminus of the PCT region, and calcitonin carboxyl-terminus peptide-1. Procalcitonin antibody refers to the specific protein which can qualitatively and quantitatively detect the PCT level. PCT level is a parameter for the diagnosis and monitoring of bacterial inflammatory diseases.
According to the report, the global Procalcitonin Antibody market is worth USD 4,963 million in 2019, and it is expected to generate USD 6,272 million in revenue by 2026, with a compound annual growth rate of roughly 3.4% from 2019 to 2026.
Get Free Sample at:
Market Driver and Constraint
The global procalcitonin antibody market is poised to be driven by a rise in the prevalence of chronic diseases such as sepsis, hepatitis, tuberculosis, and HIV. Procalcitonin antibody is used as a marker to improve identification of bacterial infections and develop antibiotic therapies, which is expected to boost the procalcitonin antibody market. Further, increase in funding for research and development by major players and government initiatives for the development of safer, efficient, and innovative products for the treatment of diseases such as cancer boost the growth of the global procalcitonin antibody market.
Region-wise Analysis
The major regions which contribute to the development of global procalcitonin antibody market mainly include North America, Asia-Pacific, Europe, Latin America, and the Middle East & Africa. North America is the global Procalcitonin Antibody market leader in 2018, with production values accounting for roughly 38% of the global. The growth of this region is mainly attributed to an increase in the adoption of new techniques in research and a rise in health care spending. Asia-Pacific is predicted to exhibit significant growth in the market, followed by Europe, owing to increasing healthcare research and rising geriatric population vulnerable to sepsis disease.
Purchase this report:
Competition Analysis
The technical barriers of procalcitonin antibody are high and the procalcitonin antibody production concentrated large companies including Thermo Fisher, Roche Diagnostics, BioMerieux, HyTest, etc. The sales revenue of the top five manufacturers accounted for 37.9% in 2016. Thermo Fisher is the largest manufacturer in the world, which sales reached 2.48g in China.
The manufacture region is concentrated in South China, East China, and Southwest China, of which East China is the largest region with the share 24.28% in 2016. The sales shares of Southwest China and South China were 15.59% and 14.79%.
Major enterprises in the global market of Procalcitonin Antibody include Thermo Fisher, Roche Diagnostics, BioMerieux, HyTest, BBI Solutions, ProSpec, Wondfo, Ningbo Medicalsystem Biotechnology, Wuhan Easy Diagnosis Biomedicine, Snibe, Vazyme Biotech, Getein Biotech, Hotgen Biotech, Lumigenex, Nanjing Norman Biological Technology, Shanghai Medicine'nest Pharmaceutical, Kitgen, Beijing KeyGen, Beijing Apis, and etc. These players have adopted strategies such as collaborations, agreements, partnerships, and new product launches to gain a competitive advantage in the procalcitonin antibody market.
Worldwide Procalcitonin Antibody Market by Type
Pharmaceutical Grade, Technical Grade, and Other.
Worldwide Procalcitonin Antibody Market by Application
Medical Industry, Scientific Research, and Other.
Table of Content
1 Report Overview
1.1 Product Definition and Scope
1.2 PEST (Political, Economic, Social and Technological) Analysis of Procalcitonin Antibody Market
…
2 Market Trends and Competitive Landscape
3 Segmentation of Procalcitonin Antibody Market by Types
4 Segmentation of Procalcitonin Antibody Market by End-Users
5 Market Analysis by Major Regions
6 Product Commodity of Procalcitonin Antibody Market in Major Countries
7 North America Procalcitonin Antibody Landscape Analysis
8 Europe Procalcitonin Antibody Landscape Analysis
9 Asia Pacific Procalcitonin Antibody Landscape Analysis
10 Latin America, Middle East & Africa Procalcitonin Antibody Landscape Analysis
11 Major Players Profile
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Profile and Recent Development
11.1.2 Market Performance
11.1.3 Product and Service Introduction
11.2 Roche Diagnostics
11.3 BioMerieux
11.4 HyTest
11.5 BBI Solutions
11.6 ProSpec
11.7 Wondfo
11.8 Ningbo Medicalsystem Biotechnology
11.9 Wuhan Easy Diagnosis Biomedicine
11.10 Snibe
11.11 Vazyme Biotech
11.12 Getein Biotech
11.13 Hotgen Biotech
11.14 Lumigenex
11.15 Nanjing Norman Biological Technology
11.16 Shanghai Medicine'nest Pharmaceutical
11.17 Kitgen
11.18 Beijing KeyGen
11.19 Beijing Apis
…
Ask for a discount at:
Target Audience:
Healthcare organizations
Research & Clinical Laboratories
Procalcitonin Antibody industry associations
Procalcitonin Antibody key stakeholders
Product managers, Procalcitonin Antibody industry administrator, C-level executives of the industries
Market research and consulting firms
Small and Medium-sized Enterprises (SMEs)
• Base Year: 2018
• Estimated Year: 2019
• Forecast Period: 2019 to 2026
Contact Us:
Global Market Monitor
One Pierrepont Plaza, 300 Cadman Plaza W, Brooklyn,
NY 11201, USA
Name: Rebecca Hall
Phone: + 1 (347) 467 7721
Email: info@globalmarketmonitor.com
Web Site: https://www.globalmarketmonitor.com
We provide more professional and intelligent market reports to complement your business decisions.
Chinese